Columbus, OH31 Active Studies

Pulmonary Embolism Clinical Trials in Columbus, OH

Find 31 actively recruiting pulmonary embolism clinical trials in Columbus, OH. Connect with local research sites and explore new treatment options.

31
Active Trials
29
Sponsors
129,247
Enrolling

Recruiting Pulmonary Embolism Studies in Columbus

About Pulmonary Embolism Clinical Trials in Columbus

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 31 pulmonary embolism clinical trials recruiting participants in Columbus, OH. These studies are seeking a combined 129,247 participants. Research is being sponsored by Stanford University, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, University of Milano Bicocca and 26 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Columbus — FAQ

Are there pulmonary embolism clinical trials in Columbus?

Yes, there are 31 pulmonary embolism clinical trials currently recruiting in Columbus, OH. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Columbus?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbus research site will contact you about next steps.

Are clinical trials in Columbus free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbus studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 31 active trials in Columbus are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 18, 2026 from ClinicalTrials.gov